Philippines FDA proposes huge fee hike to fulfil new obligations
This article was originally published in RAJ Devices
The Philippines Food and Drug Administration (formerly the Bureau of Food And Drugs), has proposed a substantial increase in the levels of fees it charges for various services, including the regulation of pharmaceuticals and medical devices1,2.
You may also be interested in...
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-four guidance documents have been posted on the tracker since its last update.
The risk of psychiatric disorders with chloroquine and hydroxychloroquine-containing medicines received renewed attention in the EU after they were being used as potential treatments for COVID-19.
New UK guidance explains how clinical trial sponsors and investigator sites can ensure that trial monitors securely process data in electronic health record systems that do not have a restricted access functionality.